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and recalculated plans were compared to the MapCHECK 
measured data as described in the previous section. 
1) 3mm shift in all translational directions to lower spine 
isocenter, 
2) ±3% and ±5% changes to overall number of monitor units 
(MU), and 
3) ±20MU change in a single beam (upper spine gantry 215°). 
Results: Table 1 shows the results of all the recalculated 
plans, with introduced changes as described in the above 
section, tested against the initial, correctly measured 
MapCHECK test. Figure 1 shows the graph representation of 
the deviations from the 3%/3mm γ-analysis (our centre's 
clinical standard test) for the plans with the changes 
introduced. The planned to measured dose compared using 
the γ-analysis is relatively insensitive to 3mm positional 
variations to lower spine isocenter as only a slightly lower 
than the initial percent pass rates are observed. This 
indicates that 3mm positional variations in fields do not 
cause large changes in the dose distribution due to high 
segment modulation. However, the 3%/3mm γ-analysis was 
more sensitive dose changes as overall ±3% in MU and changes 
of ±20MU in one field shows a greater change than positional 
variations. 
 
 
 
 
Conclusions: For multiple isocenter CSI, a small variation in 
isocenter position is unavoidable throughout the fractionated 
treatment. The results in this study indicate that 3mm 
positional changes in one isocenter with respect to the other 
may not cause detrimental changes in dose distribution. 
However, the measurements were sensitive to changes in 
overall dose and in a single field dose.  
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Purpose/Objective: Mobius3D (Mobius Medical Systems, 
Houston, TX, USA) is QA software performing 3D treatment 
plan verification. Mobius3D (M3D) uses a collapsed-cone 
algorithm for dose calculations which makes it suitable for a 
wide range of treatment technics. 
After sending the CTdataset, RTplan, RTstructure and RTdose 
from the treatment planning system (TPS) the system starts 
calculating automatically. Results are available in PDF and 
include 3D gamma evaluation, dose volume histogram (DVH) 
and region of interest (ROI) overview. 
In our clinic standard pretreatment QA is performed with a 
2D ionization chamber array placed in a phantom. Gamma 
evaluation of the composite dose is performed in one plane. 
The minimum pass rate for a treatment plan verification to 
be acceptable is 95%. 
The treatment plan verification with Mobius3D is compared 
with the standard pretreatment QA. 
Goal is to obtain a more efficient procedure of verifying 
VMAT lung SBRT plans without compromising on accuracy. 
 
Materials and Methods: Twenty five VMAT lung Stereotactic 
Body Radiation Therapy (SBRT) plans were randomly selected 
in the TPS (Pinnacle v9.2, Philips Healthcare, Best, The 
Netherlands). The absolute pretreatment measurements were 
performed with a 2D ionization chamber array (Octavius II, 
PTW, Freiburg, Germany) in a phantom and compared with 
the planar dose of the recomputed treatment plan on the 
scanned phantom. The detector array has a density override, 
as recommended by the manufacturer. If necessary the 
isocenter is moved to achieve a high dose area in the 
detector array plane. The gamma evaluation of the 
measurements are performed with in-house developed 
software. 
The CTdataset, RTplan, RTstructure and RTdose of both the 
original plan and the recalculated phantom plan are send to 
Mobius3D. 
The stereotactic approach requires a tight margin, the 
distance to agreement criterion is set to 2 mm. The dose 
difference is set to 3% if a homogeneous phantom is uses and 
5% for calculations on a heterogeneous CT set. In all cases, 
the gamma evaluation dose threshold is set to 30%. 
The gamma pass rates of the three situations are evaluated 
as well as the difference between the mean internal target 
volume (ITV) dose calculated by the TPS and by Mobius3D. 
Results:  
The gamma pass distribution per pass rate interval for 25 
treatment plan is shown in the figure. 
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Failing pass rates did not correlate between Mobius3D and 
Octavius measurements (CI = -0.2). 
The ITVmean difference between Pinnacle TPS and Mobius3D is 
used to evaluate the target coverage. The mean difference 
between Pinnacle TPS and Mobius3D is 0.6% (SD = 1.4%). 
Conclusions: There is no correlation between the results of 
Mobius3D and the Octavius measurements, which makes it 
probable that the deviation is in the verification tool rather 
than in the TPS. About 90% of the treatment plans pass the 
set criteria. With no need of machine time and an automated 
workflow Mobius3D is also for VMAT lung SBRT a highly 
efficient QA tool for treatment plan verification. 
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Purpose/Objective: In radiotherapy, tissue equivalent 
material commonly known as bolus is used for increasing 
patient surface dose. The purpose of this study was to 
investigate the dosimetric effect of air cavities between 
bolus and patient surface in VMAT treatments. Air cavities 
may occur when the fixation mask does not align with the 
contour of the patient surface due to weight loss, due to 
irregularity of the patient surface and/or insufficient 
flexibility of the bolus material. 
Materials and Methods: VMAT treatment plans were 
generated in the Eclipse treatment planning system v.10.0 
(Varian Medical Systems, Inc.). Two different arc techniques 
with 6 MV photons were used on the anthropomorphic 
Alderson ART-300A phantom: One full arc with 3 and 5 mm 
bolus linked to the treatment field, respectively, and one 
double half arc with 3 mm bolus linked to the treatment 
field. Air cavities (0, 5, 10, 15 mm) were introduced by 
moulding these into fixation masks (Figure 1B). All 
measurements were performed on a Varian 2300 iX Clinac 
using GafChromic ETB3 film. 
Results: The results show a decrease in measured dose with 
increasing air cavity (Figure 1 - Graph). The delivered dose 
without air cavity was 95.4 %, 95.3 % and 90.7 % using full arc 
with 3 and 5 mm bolus and half arc with 3 mm bolus, 
respectively. At air cavity of 5 mm the delivered dose was 
decreased to 86.8 %, 86.2 % and 87.5 % respectively, 
decreasing further at larger air cavities. All measurements 
were normalized to prescribed dose of 2 Gy. 
Conclusions: This study indicates that there is a critical 
reduction in dose at air cavities of 5 mm and above. 
Recommendations of 95% dose coverage of the planning 
target volume may therefore easily be compromised if the 
bolus material is not in place. In addition, a lower surface 
dose was observed for the half arc technique compared to 
the full arc, when using 3 mm bolus. 
We are currently conducting more measurements using 
additional target sites, bolus thicknesses and other dose 
measurement techniques to investigate the generality of our 
results. 
 
 
Figure 1 - A shows the placement of the planning target 
volume. B shows the fixation masks with the moulded air  
cavities. The graph shows the delivered surface dose from 
the three VMAT treatment plans normalized to 2 Gy.  
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